Literature DB >> 10878776

Correlation of clinical course with magnetic resonance imaging in tuberculous myelopathy.

A K Jain1, A Jena, I K Dhammi.   

Abstract

Sixty cases of spinal tuberculosis with neurological deficit treated with 'middle path regimen' were analysed and therapeutic response was correlated with the magnetic resonance imaging (MRI) observations. Tuberculous lesions were found to be more extensive than seen on plain X-ray in 60% of the cases. MRI showed the involvement of one or both pedicles in nearly 90% of the cases, in addition to the vertebral body lesion as seen in the X-rays. The patients showing predominantly extradural collection of fluid with relatively preserved cord size, and MRI evidence of myelitis/oedema, improved neurologically with treatment. The myelomalacia of cord was found to be a poor prognostic sign for neural recovery. The magnitude of thinning of cord did not always correlate with severity of neural deficit, however, thinning of cord in association with myelomalacia carried a bad prognosis. The complete neural recovery is not expected in patients with syrinx formation proximal or distal to the diseased spine, either with antitubercular drugs or after mechanical decompression. MRI changes in dura-subarachnoid complex suggesting arachnoiditis generally correlated with poor neural recovery. MRI provided a reliable guide to the level and extent of surgical decompression, and prognostication of the outcome of therapeutic measures.

Entities:  

Mesh:

Year:  2000        PMID: 10878776

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  10 in total

Review 1.  Tuberculosis of spine: neurological deficit.

Authors:  Anil K Jain; Jaswant Kumar
Journal:  Eur Spine J       Date:  2012-05-08       Impact factor: 3.134

2.  Magnetic resonance evaluation of tubercular lesion in spine.

Authors:  Anil Kumar Jain; Ravi Sreenivasan; Namita Singh Saini; Sudhir Kumar; Saurabh Jain; Ish Kumar Dhammi
Journal:  Int Orthop       Date:  2011-10-29       Impact factor: 3.075

3.  Diagnostic accuracy of whole spine magnetic resonance imaging in spinal tuberculosis validated through tissue studies.

Authors:  Rishi M Kanna; Naveen Babu; Muhil Kannan; Ajoy P Shetty; S Rajasekaran
Journal:  Eur Spine J       Date:  2019-06-14       Impact factor: 3.134

4.  Tetraplegia associated with post-operative syringomyelia in spinal tuberculosis: a result of an epidural compartment syndrome?

Authors:  Nishit Bhatnagar; Ankit Kataria; Purushotham Lingaiah; Yugal Karkhur
Journal:  Spinal Cord Ser Cases       Date:  2019-02-12

5.  Familial adhesive arachnoiditis associated with syringomyelia.

Authors:  V Pasoglou; N Janin; M Tebache; T J Tegos; J D Born; L Collignon
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-30       Impact factor: 3.825

6.  Neurological recovery in patients of old healed tubercular rigid kyphosis with myelopathy treated with transpedicular decancellation osteotomy.

Authors:  Saumyajit Basu; Sreeramalingam Rathinavelu
Journal:  Eur Spine J       Date:  2012-03-29       Impact factor: 3.134

7.  Evaluation of prognostic factors in medically treated patients of spinal tuberculosis.

Authors:  Ravindra Kumar Garg; Tushar Raut; Hardeep Singh Malhotra; Anit Parihar; Madhumati Goel; Amita Jain; Rajesh Verma; Maneesh Kumar Singh
Journal:  Rheumatol Int       Date:  2013-08-03       Impact factor: 2.631

8.  Clinicoradiologic Profile of Involvement and Healing in Tuberculosis of the Spine.

Authors:  R Singh; N K Magu; R K Rohilla
Journal:  Ann Med Health Sci Res       Date:  2016 Sep-Oct

9.  Simultaneous 18F-FDG PET/MRI in tuberculous spondylitis: an independent method for assessing therapeutic response - case series.

Authors:  Ikchan Jeon; Eunjung Kong; Sang Woo Kim
Journal:  BMC Infect Dis       Date:  2019-10-15       Impact factor: 3.090

10.  Tuberculosis of spine: Research evidence to treatment guidelines.

Authors:  Anil K Jain
Journal:  Indian J Orthop       Date:  2016 Jan-Feb       Impact factor: 1.251

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.